Aim and objectives

Goal:

The primary goal of this workshop is to strengthen and facilitate the rapid and effective implementation of the latest WHO guidance on the management of drug-resistant tuberculosis (DR-TB) in the African region. By bringing together key stakeholders, experts, and representatives from participating countries, we aim to accelerate the adoption of evidence-based practices and enhance programmatic approaches to DR-TB control.

Objectives:

• Define the status/uptake of the programmatic introduction of the shorter regimens in the African region.
• Common knowledge and understanding of the latest WHO Guidance on the management of DR TB and global support mechanisms for countries to access quality assured medicines, diagnostics, technical assistance, and funding.
• Self-assessment by country on the programmatic introduction status, identify implementation gaps and define the country priorities.
• Plans for actions required for full implementation of the latest WHO guidance on the management of DR TB in each country.
• Improve the capacity of countries representatives and regional consultants on the technical details of the WHO guidance.

Expected Results

By the end of the workshop, we anticipate the following outcomes:

• Increased awareness of the latest WHO guidance among participants.
• Clear identification of country-specific priorities and gaps.
• Agreed-upon action plans for accelerating the uptake of recommended treatment regimens and timelines.

Aim and objectives

Goal:

The primary goal of this workshop is to strengthen and facilitate the rapid and effective implementation of the latest WHO guidance on the management of drug-resistant tuberculosis (DR-TB) in the African region. By bringing together key stakeholders, experts, and representatives from participating countries, we aim to accelerate the adoption of evidence-based practices and enhance programmatic approaches to DR-TB control.

Objectives:

• Define the status/uptake of the programmatic introduction of the shorter regimens in the African region.
• Common knowledge and understanding of the latest WHO Guidance on the management of DR TB and global support mechanisms for countries to access quality assured medicines, diagnostics, technical assistance, and funding.
• Self-assessment by country on the programmatic introduction status, identify implementation gaps and define the country priorities.
• Plans for actions required for full implementation of the latest WHO guidance on the management of DR TB in each country.
• Improve the capacity of countries representatives and regional consultants on the technical details of the WHO guidance.

Expected Results

By the end of the workshop, we anticipate the following outcomes:

• Increased awareness of the latest WHO guidance among participants.
• Clear identification of country-specific priorities and gaps.
• Agreed-upon action plans for accelerating the uptake of recommended treatment regimens and timelines.

The Conference on Innovations in Tuberculosis  will be held in Kampala, Uganda from 3 to 5 July 2024. This event will focus on disseminating clinically relevant innovations & discuss their implementation in Africa, considering region-specific patterns

The main objectives of this Conference are:

• Create an African dissemination platform for an unbiased, scientific exchange and education regarding clinically relevant advances in Tuberculosis;
• Provide educational settings to discuss the clinical translation of recent developments considering regional epidemic patterns and healthcare systems;
• Share real-world experience and facilitate evidence-based program implementation;
• Foster new and lasting cross-disciplinary collaborations aiming to strengthen Tuberculosis research and management in high-disease-burden regions;
• Encourage early-career investigators to actively participate in the program and support their career trajectory toward future leaders in Tuberculosis research.

For more information click here

The Conference on Innovations in Tuberculosis  will be held in Kampala, Uganda from 3 to 5 July 2024. This event will focus on disseminating clinically relevant innovations & discuss their implementation in Africa, considering region-specific patterns

The main objectives of this Conference are:

• Create an African dissemination platform for an unbiased, scientific exchange and education regarding clinically relevant advances in Tuberculosis;
• Provide educational settings to discuss the clinical translation of recent developments considering regional epidemic patterns and healthcare systems;
• Share real-world experience and facilitate evidence-based program implementation;
• Foster new and lasting cross-disciplinary collaborations aiming to strengthen Tuberculosis research and management in high-disease-burden regions;
• Encourage early-career investigators to actively participate in the program and support their career trajectory toward future leaders in Tuberculosis research.

For more information click here

The Conference on Innovations in Tuberculosis  will be held in Kampala, Uganda from 3 to 5 July 2024. This event will focus on disseminating clinically relevant innovations & discuss their implementation in Africa, considering region-specific patterns

The main objectives of this Conference are:

• Create an African dissemination platform for an unbiased, scientific exchange and education regarding clinically relevant advances in Tuberculosis;
• Provide educational settings to discuss the clinical translation of recent developments considering regional epidemic patterns and healthcare systems;
• Share real-world experience and facilitate evidence-based program implementation;
• Foster new and lasting cross-disciplinary collaborations aiming to strengthen Tuberculosis research and management in high-disease-burden regions;
• Encourage early-career investigators to actively participate in the program and support their career trajectory toward future leaders in Tuberculosis research.

For more information click here

The ADB-ADBI policy dialogue, “Investing in Climate Change Adaptation: Innovations in Climate-Induced Infectious Diseases Control for Malaria and Tuberculosis,” aims to explore climate change's impact on health, focusing on infectious diseases like malaria and tuberculosis (TB).

The event will showcase innovative technologies and data analysis tools for understanding and predicting disease patterns in collaboration with Nagasaki University, the Global Fund, Malaria No More Japan, and the Stop TB Partnership. 

The event will begin with Asian Development Bank Institute (ADBI) and Asian Development Bank (ADB) experts setting the context, followed by Session 1, which will provide an overview of climate change impacts on communicable diseases, given by experts from Malaria No More Japan, Nagasaki University, the Stop TB Partnership, and the Global Fund. Subsequent sessions will discuss adaptation solutions for climate-induced malaria and tuberculosis, with inputs from experts from around the globe. Thematic sessions will be followed by country presentations on the burden of TB and malaria and strategies for their control. 

Objectives

• Bring together high-risk and donor countries to facilitate discussions on the impact of climate change and generate ideas on improving investments and leveraging technology for controlling communicable diseases.
• Enhance the partnerships between ADB–ADBI and ADB developing member countries on climate-induced infectious diseases with particular emphasis on malaria and TB control.

Output

• Continue dialogue with stakeholders to address the impacts of climate change on health.
• Incorporate policy messages into T20, T7, and COP 29 policy briefs and relevant ADBI publications.

Partners

• ADB (Health Sector Group)
• Malaria No More Japan
• Stop TB Partnership
• Global Fund

The ADB-ADBI policy dialogue, “Investing in Climate Change Adaptation: Innovations in Climate-Induced Infectious Diseases Control for Malaria and Tuberculosis,” aims to explore climate change's impact on health, focusing on infectious diseases like malaria and tuberculosis (TB).

The event will showcase innovative technologies and data analysis tools for understanding and predicting disease patterns in collaboration with Nagasaki University, the Global Fund, Malaria No More Japan, and the Stop TB Partnership. 

The event will begin with Asian Development Bank Institute (ADBI) and Asian Development Bank (ADB) experts setting the context, followed by Session 1, which will provide an overview of climate change impacts on communicable diseases, given by experts from Malaria No More Japan, Nagasaki University, the Stop TB Partnership, and the Global Fund. Subsequent sessions will discuss adaptation solutions for climate-induced malaria and tuberculosis, with inputs from experts from around the globe. Thematic sessions will be followed by country presentations on the burden of TB and malaria and strategies for their control. 

Objectives

• Bring together high-risk and donor countries to facilitate discussions on the impact of climate change and generate ideas on improving investments and leveraging technology for controlling communicable diseases.
• Enhance the partnerships between ADB–ADBI and ADB developing member countries on climate-induced infectious diseases with particular emphasis on malaria and TB control.

Output

• Continue dialogue with stakeholders to address the impacts of climate change on health.
• Incorporate policy messages into T20, T7, and COP 29 policy briefs and relevant ADBI publications.

Partners

• ADB (Health Sector Group)
• Malaria No More Japan
• Stop TB Partnership
• Global Fund